{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:13:32Z","timestamp":1792790012682,"version":"4.5.0"},"reference-count":43,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIHR Policy Research Programme (NIBSC Regulatory Science Research Unit)","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Group A Streptococcus (GAS) is an important global human pathogen, with a wide range of disease presentations, from mild mucosal infections like pharyngitis to invasive diseases such as toxic shock syndrome. The effect on health and mortality from GAS infections is substantial worldwide, particularly from autoimmune sequelae-like rheumatic heart disease (RHD), and there is currently no licenced vaccine. We investigated protein antigens targeting a broad range of GAS disease presentations as vaccine components in individual and combination formulations. The potency and functional immunity generated were evaluated and compared between groups. Antibodies against all components were found in pooled human IgG (IVIG) and an immune response generated following the subcutaneous immunisation of mice. A combination immunisation showed a reduction in IgG response for SpyCEP but an increase for Cpa and Mac-1 (IdeS). An opsonophagocytosis assay (OPA) showed the killing of GAS with immune sera against M protein and combination groups, with a lower killing activity observed for immune sera against other individual antigens. Specific antigen assays showed functional immunity against SpyCEP and Mac-1 from both individual and combination immunisations, with the activity correlating with antibody titres. However, efficient blocking of the binding activity of Cpa to collagen I and fibronectin could not be demonstrated with immune sera or purified IgG. Our data indicate that combination immunisations, while effective at covering a broader range of virulence factors, can also affect the immune response generated. Further, our results showed that an OPA alone is inadequate for understanding protection from vaccination, particularly when considering protection from immune evasion factors and evaluation of the colonisation leading to pharyngitis.<\/jats:p>","DOI":"10.3390\/vaccines9091025","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T21:47:11Z","timestamp":1631742431000},"page":"1025","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Multicomponent Vaccines against Group A Streptococcus Can Effectively Target Broad Disease Presentations"],"prefix":"10.3390","volume":"9","author":[{"given":"Helen A.","family":"Shaw","sequence":"first","affiliation":[{"name":"The National Institute of Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, London EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ozanne","sequence":"additional","affiliation":[{"name":"The National Institute of Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, London EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keira","family":"Burns","sequence":"additional","affiliation":[{"name":"The National Institute of Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, London EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatme","family":"Mawas","sequence":"additional","affiliation":[{"name":"The National Institute of Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, London EN6 3QG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, Regional, and National Burden of Rheumatic Heart Disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.vaccine.2019.12.005","article-title":"Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study","volume":"38","author":"Pastural","year":"2020","journal-title":"Vaccine"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sekuloski, S., Batzloff, M.R., Griffin, P., Parsonage, W., Elliott, S., Hartas, J., O\u2019Rourke, P., Marquart, L., Pandey, M., and Rubin, F.A. (2018). Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198658"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: Paving a path for accelerated development","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00618-16","DOI":"10.1128\/mBio.00618-16","article-title":"Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models","volume":"7","author":"Pandey","year":"2016","journal-title":"mBio"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"111.015693","DOI":"10.1074\/mcp.M111.015693","article-title":"Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: The Group A Streptococcus Case","volume":"11","author":"Bensi","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jinf.2016.02.002","article-title":"Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG","volume":"72","author":"Reglinski","year":"2016","journal-title":"J. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e00693-19","DOI":"10.1128\/mBio.00693-19","article-title":"An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model","volume":"10","author":"Carnathan","year":"2019","journal-title":"mBio"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41588-019-0417-8","article-title":"Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics","volume":"51","author":"Davies","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.vaccine.2016.03.073","article-title":"Status of research and development of vaccines for Streptococcus pyogenes","volume":"34","author":"Steer","year":"2016","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.vaccine.2018.05.056","article-title":"Development of an opsonophagocytic killing assay for group a streptococcus","volume":"36","author":"Jones","year":"2018","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-0716-0467-0_26","article-title":"An Opsonophagocytic Killing Assay for the Evaluation of Group A Streptococcus Vaccine Antisera","volume":"2136","author":"McGregor","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rivera-Hernandez, T., Rhyme, M.S., Cork, A.J., Jones, S., Segui-Perez, C., Brunner, L., Richter, J., Petrovsky, N., Lawrenz, M., and Goldblatt, D. (2020). Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies. mBio, 11.","DOI":"10.1128\/mBio.00122-20"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"33228","DOI":"10.1074\/jbc.M502896200","article-title":"Streptococcus pyogenes Collagen Type I-binding Cpa Surface Protein","volume":"280","author":"Kreikemeyer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1128\/JB.00071-10","article-title":"Roles of Minor Pilin Subunits Spy0125 and Spy0130 in the Serotype M1 Streptococcus pyogenes Strain SF370","volume":"192","author":"Smith","year":"2010","journal-title":"J. Bacteriol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1128\/JB.01539-06","article-title":"MalE of Group A Streptococcus Participates in the Rapid Transport of Maltotriose and Longer Maltodextrins","volume":"189","author":"Shelburne","year":"2007","journal-title":"J. Bacteriol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1128\/IAI.00477-06","article-title":"Maltodextrin Utilization Plays a Key Role in the Ability of Group A Streptococcus to Colonize the Oropharynx","volume":"74","author":"Shelburne","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm1201-1298","article-title":"Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis","volume":"7","author":"Lei","year":"2001","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1128\/IAI.70.12.6880-6890.2002","article-title":"Opsonophagocytosis-Inhibiting Mac Protein of Group A Streptococcus: Identification and Characteristics of Two Genetic Complexes","volume":"70","author":"Lei","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000332940","article-title":"Streptococcal IdeS and Its Impact on Immune Response and Inflammation","volume":"4","year":"2012","journal-title":"J. Innate Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/432485","article-title":"Specific C-Terminal Cleavage and Inactivation of Interleukin-8 by Invasive Disease Isolates ofStreptococcus pyogenes","volume":"192","author":"Edwards","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.csbj.2020.03.004","article-title":"Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes","volume":"18","author":"McKenna","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1365-2958.2010.07065.x","article-title":"Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract","volume":"76","author":"Kurupati","year":"2010","journal-title":"Mol. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1096\/fj.09-145631","article-title":"Streptococcus pyogenes SpyCEP: A chemokine-inactivating protease with unique structural and biochemical features","volume":"24","author":"Zingaretti","year":"2010","journal-title":"FASEB J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1016\/j.vaccine.2009.06.042","article-title":"Impact of immunization against SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and Streptococcus equi","volume":"27","author":"Turner","year":"2009","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"52789","DOI":"10.1074\/jbc.M410698200","article-title":"Insight of Host Immune Evasion Mediated by Two Variants of Group A Streptococcus Mac Protein","volume":"279","author":"Agniswamy","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-07602-0","article-title":"Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses","volume":"7","author":"Loh","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/380491","article-title":"Identification of New Candidate Vaccine Antigens Made byStreptococcus pyogenes:Purification and Characterization of 16 Putative Extracellular Lipoproteins","volume":"189","author":"Lei","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/intimm\/9.11.1723","article-title":"Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus","volume":"9","author":"Brandt","year":"1997","journal-title":"Int. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sheppard, C.L., Groves, N., Andrews, N., Litt, D.J., Fry, N.K., Southern, J., and Miller, E. (2019). The Genomics of Streptococcus Pneumoniae Carriage Isolates from UK Children and Their Household Contacts, Pre-PCV7 to Post-PCV13. Genes, 10.","DOI":"10.3390\/genes10090687"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e00499-13","DOI":"10.1128\/mBio.00499-13","article-title":"IgG Protease Mac\/IdeS Is Not Essential for Phagocyte Resistance or Mouse Virulence of M1T1 Group A Streptococcus","volume":"4","author":"Okumura","year":"2013","journal-title":"mBio"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","article-title":"Humanized Mouse Models of Clinical Disease","volume":"12","author":"Walsh","year":"2017","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1111\/febs.13092","article-title":"Structural and functional analysis of the fibronectin-binding protein FNE fromStreptococcus equispp.equi","volume":"281","author":"Tiouajni","year":"2014","journal-title":"FEBS J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"33858","DOI":"10.1074\/jbc.M110.149385","article-title":"A Highly Unusual Thioester Bond in a Pilus Adhesin Is Required for Efficient Host Cell Interaction*","volume":"285","author":"Pointon","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1074\/jbc.M113.523761","article-title":"Structural Model for Covalent Adhesion of the Streptococcus pyogenes Pilus through a Thioester Bond","volume":"289","author":"Paterson","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/IAI.66.3.974-979.1998","article-title":"Immunoglobulins to Group A Streptococcal Surface Molecules Decrease Adherence to and Invasion of Human Pharyngeal Cells","volume":"66","author":"Fluckiger","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15825","DOI":"10.1038\/srep15825","article-title":"Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulin","volume":"5","author":"Reglinski","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"C\u00e1ceres, C., Cardenas-Garcia, S., Jain, A., Gay, L., Carnaccini, S., Seibert, B., Ferreri, L., Geiger, G., Jasinskas, A., and Nakajima, R. (2021). Development of a Novel Live Attenuated Influenza A Virus Vaccine Encoding the IgA-Inducing Protein. Vaccines, 9.","DOI":"10.20944\/preprints202106.0180.v1"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1086\/426396","article-title":"Suppression and Modulation of Cellular and Humoral Immune Responses toHaemophilus influenzaeType B (Hib) Conjugate Vaccine in Hib\u2013Diphtheria-Tetanus Toxoids\u2013Acellular Pertussis Combination Vaccines: A Study in a Rat Model","volume":"191","author":"Mawas","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00430-014-0353-2","article-title":"Vaccination with Streptococcus pyogenes nuclease A stimulates a high antibody response but no protective immunity in a mouse model of infection","volume":"204","author":"Radcliff","year":"2014","journal-title":"Med. Microbiol. Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/9\/1025\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:00:07Z","timestamp":1760166007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/9\/1025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["vaccines9091025"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9091025","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]}}}